CalciMedica (CALC) Prepaid Assets (2019 - 2026)
CalciMedica's (CALC) quarterly Prepaid Assets came in at $122000.0 in Q1 2026, down 38.07% YoY from $197000.0 in Q1 2025, and down 52.9% on a QoQ basis from $259000.0 in Q4 2025.
CalciMedica (CALC) Prepaid Assets (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Prepaid Assets data on file, last reported at $122000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 38.07% year-over-year to $122000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122000.0 (down 38.07% YoY) and the FY2025 annual result came in at $259000.0, up 4.44% from the prior year.
- Prepaid Assets fell to $122000.0 in Q1 2026, from $259000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.9 million in Q1 2022 to a low of $122000.0 in Q1 2026.
- A 5-year average of $995142.9 and a median of $597000.0 in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 92.55% — and 2023, when it jumped 101.93%.
- Tracing CALC's Prepaid Assets over 5 years: stood at $254000.0 in 2022, then increased by 16.54% to $296000.0 in 2023, then declined by 16.22% to $248000.0 in 2024, then climbed by 4.44% to $259000.0 in 2025, then slumped by 52.9% to $122000.0 in 2026.
- The last three Prepaid Assets figures came in at $122000.0 (Q1 2026), $259000.0 (Q4 2025), and $539000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 575,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | 539,000.00 |
| Jun 30, 2025 | 655,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Dec 31, 2024 | 248,000.00 |
| Dec 31, 2023 | 296,000.00 |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 2.94 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 1.94 Mn |
| Jun 30, 2021 | 2.47 Mn |
| Mar 31, 2021 | 3.13 Mn |
| Dec 31, 2020 | 1.46 Mn |